Expérimentation préclinique et recherche clinique
Expérimentation préclinique et recherche clinique
Contact
Arronax Nantes > Expérimentation préclinique et recherche clinique > Nos Publications

Nos Publications

  • Glucose Metabolism Quantified by SUVmax on Baseline FDG-PET/CT Predicts Survival in Newly Diagnosed Multiple Myeloma Patients: Combined Harmonized Analysis of Two Prospective Phase III Trials, Michaud-Robert A-V, Zamagni E, Carlier T, Bailly C, Jamet B, Touzeau C, et al, Cancers. 6 sept 2020;12(9):2532. https://doi.org/10.3390/cancers12092532

  • Functional Imaging for Therapeutic Assessment and Minimal Residual Disease Detection in Multiple Myeloma, Jamet B, Zamagni E, Nanni C, Bailly C, Carlier T, Touzeau C, et al, IJMS. 29 juill 2020;21(15):5406. https://doi.org/10.3390/ijms21155406

  • FDG-PET/CT, a Promising Exam for Detecting High-Risk Myeloma Patients?, Michaud-Robert A-V, Jamet B, Bailly C, Carlier T, Moreau P, Touzeau C, et al, Cancers. 28 mai 2020;12(6):1384. https://doi.org/10.3390/cancers12061384

  • Editorial: Nuclear Medicine in the Context of Personalized Medicine, Barbet J, Bernaudin M, Payoux P, Cicone F, Gaugler M-H, Kraeber-Bodéré F, Front Med. 9 juin 2020;7:252. doi:10.3389/fmed.2020.00252

  • What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between 89Zr- and 64Cu-Labeled Anti-CD138 in a Preclinical Syngeneic Model, Bailly C, Gouard S, Guérard F, Chalopin B, Carlier T, Faivre-Chauvet A, et al., IJMS. 24 mai 2019;20(10):2564.

  • Preliminary results of a 68 Ga‐PSMA PET/CT prospective study in prostate cancer patients with occult recurrence: Diagnostic performance and impact on therapeutic decision‐making, Rousseau C, Le Thiec M, Ferrer L, Rusu D, Rauscher A, Maucherat B, et al. , Prostate. 17 août 2019;pros.23869

  • Potential for Nuclear Medicine Therapy for Glioblastoma Treatment, Bailly C, Vidal A, Bonnemaire C, Kraeber-Bodéré F, Chérel M, Pallardy A, et al., Front Pharmacol. 10 juill 2019;10:772.

  • FDG PET in Multiple Myeloma, Jamet B., Bailly C, Carlier T., Michaud A.V., Touzeau C., Moreau P., Bodet-Milin C., Kraeber-Bodere F., In: Molecular imaging in multiple myeloma. Springer.

  • Clinical Results in Medullary Thyroid Carcinoma Suggest High Potential of Pretargeted Immuno-PET for Tumor Imaging and Theranostic Approaches, Bodet-Milin C, Bailly C, Touchefeu Y, Frampas E, Bourgeois M, Rauscher A, et al., Front Med. 4 juin 2019;6:124.

  • Exploring Tumor Heterogeneity Using PET Imaging: The Big Picture, Bailly C, Bodet-Milin C, Bourgeois M, Gouard S, Ansquer C, Barbaud M, et al., Cancers. 31 août 2019;11(9):1282.

voir plus de résultats